537 PPARG amplification is associated with lack of response to anti-PD1 in muscle-invasive urothelial cancer

• Evisa Gjini,
• Michaela Bowden,
• Stefan Kirov

Affiliations

Evisa Gjini

Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Michaela Bowden

Bristol-Myers Squibb, Cambridge, MA, USA

Stefan Kirov

Flare Therapeutics, Cambridge, MA, USA